BCWORLDPHARM (200780) Financial Statements

OverviewFinancialsChecksFilings

In fiscal year 2025, BCWORLDPHARM (200780) reported revenue of 75.8 billion KRW.

Income Statement

YearRevenueOp ProfitNet IncomeSource
202575.8 billion KRW2.0 billion KRW-3.1 billion KRW[source]
202474.8 billion KRW1.5 billion KRW-3.3 billion KRW[source]
202375.1 billion KRW6.4 billion KRW2.9 billion KRW[source]
202272.7 billion KRW1.9 billion KRW60 million KRW[source]
202162.1 billion KRW-1.8 billion KRW-2.2 billion KRW[source]

Balance Sheet

YearTotal AssetsTotal LiabilitiesTotal EquitySource
2025149.3 billion KRW78.0 billion KRW71.3 billion KRW[source]
2024147.4 billion KRW70.1 billion KRW77.3 billion KRW[source]
2023155.2 billion KRW71.9 billion KRW83.3 billion KRW[source]
2022151.2 billion KRW69.7 billion KRW81.5 billion KRW[source]
2021153.6 billion KRW69.9 billion KRW83.6 billion KRW[source]
Financials & Filings: DART (traceable by receipt number) · Prices: Financial Services Commission · Data Sources · Last checked: 2026-08-29 · About · Delisting market cap threshold: KOSPI 5B KRW / KOSDAQ 4B KRW (per listing rules) · This page provides factual information, not investment advice